- Activity pressure is positive on the latest completed week.
BCDA
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
Biocardia Inc · Healthcare · Biotechnology
Latest close
0.85 USD
2.9%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -24.9% below the Trend Line and sits at 4.6% of its 52-week range. The latest completed week returned 2.9%, after a -29.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.
Setup score
14
out of 100
Latest Close
0.85 USD
24 Jul 2026
1W Return
2.9%
latest completed week
4W Return
-29.2%
short-term follow-through
12W Return
-23.4%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 37.60% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.9%
Latest completed week; four-week move -29.2%.
Indicator stack
0/58
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.60%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
42 relevant articles in the latest sentiment read.
Event risk
11d
Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -24.9% below the Trend Line and sits at 4.6% of its 52-week range. The latest completed week returned 2.9%, after a -29.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0512-week average 0.03
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -29.2% over four weeks, -23.4% over 12 weeks, and -63.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.01Latest activity-pressure read.
Pressure change102.5%Four-week change in activity pressure.
Leadership-41.47Latest relative-leadership reading.
RS change-52.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 58%
Model confidence 55%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength71/100Blend of value, momentum, and quality. Underlying universe rank 30; rank 1 is best.
Value60/100Relative valuation strength. Underlying universe rank 41; rank 1 is best.
Quality58/100Profitability and accounting quality. Underlying universe rank 43; rank 1 is best.
Momentum60/100Medium-term price momentum. Underlying universe rank 41; rank 1 is best.
Growth60/100Revenue and earnings growth. Underlying universe rank 41; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -61.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- - Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 2/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -68.8% Net share repurchases relative to market value.
- Shareholder yield
- -68.8% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity17 / 3
17 acquisitions and 3 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment55/100
Weighted news tone is neutral across 42 relevant articles.
12 positive · 27 neutral · 3 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings11dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-64.3%Distance below the 52-week high.
13-week volatility11.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher8 of 2615 weeks finished lower.
Best week+24.0%Week of 26 Jun.
Worst week-23.8%Week of 10 Jul.
Latest week+2.9%Week of 24 Jul.
Shape of recent returns
Strong gains5
Modest gains3
Flat weeks3
Modest losses5
Sharp losses10
Recent vol11.7%13-week weekly-return volatility.
Base vol10.7%52-week weekly-return volatility.
Up/down split19/28Count of positive and negative weeks in the 52-week window.
Average skew8.3% / -8.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Biotechnology
4-week rank- / 100
Group average0.5%
Trend breadth67.0%
Trend67.0%active weekly trend signals
MD72.0%positive activity pressure
RS65.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape17/100
Trend, activity pressure, participation, and risk combine to a 17/100 tape read.
Indicator analysis21/100Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.
Activity pressure 0.05; No reversal markers Next-Week ExpectancyNegative 37.60%Next-week expectancy is negative with a 37.60% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors62/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 98 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment55/100Weighted news tone is neutral across 42 relevant articles.
BioCardia Inc (BCDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution Insiders17 / 317 acquisitions and 3 disposals in the latest 180-day insider tape.
Earnings11dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 0.85 USD | 2.9% | 1.13 USD | 3.56 USD | 0.01 | -41.47 | 1.1M | Off |
| 17 Jul 2026 | 0.83 USD | -9.7% | 1.15 USD | 3.65 USD | 0.37 | -45.50 | 1.9M | Off |
| 10 Jul 2026 | 0.91 USD | -23.8% | 1.16 USD | 3.83 USD | 0.24 | -43.53 | 3.3M | Off |
| 3 Jul 2026 | 1.20 USD | 0.0% | 1.18 USD | 4.05 USD | 0.01 | -26.52 | 1.8M | Off |
| 26 Jun 2026 | 1.20 USD | 24.0% | 1.18 USD | 4.31 USD | -0.40 | -27.20 | 13.3M | Off |
| 19 Jun 2026 | 0.97 USD | 9.9% | 1.19 USD | 4.56 USD | -0.86 | -44.97 | 2.5M | Off |
| 12 Jun 2026 | 0.88 USD | -14.6% | 1.21 USD | 4.80 USD | -0.74 | -49.68 | 11.5M | Off |
| 5 Jun 2026 | 1.03 USD | 10.8% | 1.22 USD | 5.02 USD | -0.49 | -41.12 | 151.6M | Off |
| 29 May 2026 | 0.93 USD | -2.6% | 1.23 USD | 5.22 USD | -0.19 | -50.25 | 413.3K | Off |
| 22 May 2026 | 0.95 USD | -5.4% | 1.24 USD | 5.40 USD | 0.01 | -48.57 | 673.2K | Off |
| 15 May 2026 | 1.01 USD | -9.0% | 1.26 USD | 5.57 USD | 0.23 | -45.98 | 1.1M | Off |
| 8 May 2026 | 1.11 USD | 0.0% | 1.27 USD | 5.72 USD | 0.27 | -42.20 | 5.2M | Off |
| 1 May 2026 | 1.11 USD | -4.3% | 1.28 USD | 5.90 USD | 0.24 | -40.83 | 243.6K | Off |
| 24 Apr 2026 | 1.16 USD | -1.7% | 1.29 USD | 6.09 USD | 0.40 | -38.84 | 389.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.